Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022

By Shimazawa M.   Takiguchi Y.   Umemura K.   Kondo K.   Nakashima M.  

European Journal of Pharmacology, Vol. 328, Iss. 2, 1997-09 ,pp. : 183-189

Elsevier

Access to resources Recommend Favorite

Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo

By Yamamoto N.   Yokota K.   Yamashita A.   Oda M.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 225-231

Elsevier

Access to resources Recommend Favorite

Determination of the New Antiplatelet Agent Ticagrelor in Tablets by Stability-Indicating HPLC Method

By  

Current Pharmaceutical Analysis, Vol. 10, Iss. 4, 2014-11 ,pp. : 279-283

Bentham Science Publishers

Access to resources Recommend Favorite

Action Mechanism of Antihistamines and the New Antihistamines

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 5, 2005-10 ,pp. : 465-475

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism of Action and Potential for Use of Tea Catechin as an Antiinfective Agent

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 57-62

Bentham Science Publishers

Access to resources Recommend Favorite